Fluphenazine
Sponsors
Universitair Medisch Centrum Utrecht, Tufts Medical Center, Centre for Addiction and Mental Health, Technical University of Munich, Hannover Medical School
Conditions
Anxiety DisordersDementiaDepressionPathological GamblingPsoriasisPsychosomatic DisordersSchizoaffective DisordersSchizophrenia
Phase 2
Phase 3
Phase 4
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
CompletedNCT02307396
Start: 2015-02-01End: 2016-06-22Updated: 2018-10-11
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.
RecruitingCTIS2023-506602-39-00
Start: 2024-08-01Target: 310Updated: 2025-03-04